NCIt definition : A preparation of autologous T-lymphocytes that have been transduced with a retroviral
vector encoding for a chimeric antigen receptor (CAR) specific for the human tumor-associated
antigen (TAA) B-cell maturation antigen (BCMA; tumor necrosis factor receptor superfamily
member 17; TNFRSF17) fused to the co-stimulatory domain of 4-1BB (CD137), with potential
immunostimulating and antineoplastic activities. Upon administration, the autologous
anti-BCMA-CAR-4-1BB-expressing T-cells NXC-201 specifically recognize and induce selective
toxicity in BCMA-expressing tumor cells. BCMA, a receptor for both a proliferation-inducing
ligand (APRIL) and B-cell activating factor (BAFF), is a member of the tumor necrosis
factor receptor superfamily (TNFRSF). BCMA, found on the surfaces of plasma cells
and overexpressed on malignant plasma cells, plays a key role in plasma cell survival.;
Molecule name : HBI 0101; HBI-0101; NXC-201; NXC 201;